Clinical Trial Update: Randomised Trial in Waldenstrom's Macroglobulinaemia [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial in Waldenström's macroglobulinaemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Waldenström Macroglobulinaemia

Snippet

Sponsor: University College, London | Conditions: Waldenstrom's Macroglobulinaemia | Phase 2 | Status: COMPLETED